Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
10.14
+0.63 (6.62%)
At close: May 20, 2025, 4:00 PM
10.20
+0.06 (0.59%)
After-hours: May 20, 2025, 4:20 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $773.03 million as of May 20, 2025. Its market cap has increased by 2.37% in one year.
Market Cap
773.03M
Enterprise Value
249.97M
1-Year Change
2.37%
Ranking
Category
Stock Price
$10.14
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $773.03M, an increase of 9.79%. That is a compound annual growth rate of 1.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 725.00M | -45.67% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.62B |
| Johnson & Johnson | 369.72B |
| AbbVie | 326.52B |
| Novo Nordisk | 305.65B |
| UnitedHealth Group | 291.72B |
| Abbott Laboratories | 235.23B |
| Novartis AG | 219.90B |
| AstraZeneca | 215.95B |